Filing Details

Accession Number:
0001437749-19-010580
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-21 16:10:16
Reporting Period:
2019-05-17
Accepted Time:
2019-05-21 16:10:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
810509 Navidea Biopharmaceuticals Inc. NAVB In Vitro & In Vivo Diagnostic Substances (2835) 311080091
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1761366 Kathryn Sarah Rouan 4995 Bradenton Ave., Suite 240
Dublin OH 43017
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-17 3,350 $1.46 8,350 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct